Replies to post #103910 on Ayala Pharmaceuticals Inc (ADXS)

[hdwrsft]

Lots of bios are using advanced genomic analysis techniques to gain a better understanding and approach for their specific science.

This is a no brainer.

Not doing such collaborations in genomics/bioinformatics would lead to a competitive disadvantage.

Jmho

[hdwrsft]

If they run another secondary, you'll know they needed the cash to survive another day.

Which we 'all kinda know already...that they'll need lots-n-lots more $$$$$$.

[raja48185]

This is PR is fluff. I hope the company is not trying to run another secondary.

We all know very well by now the Modus Operandi. (Wonder why there is no update regarding any of their other dealings, like OS Therapeutics?). All that talk of partnership has become out of fashion - knowing very well what is an open secret by now and the market knows; the company is raising money to survive, not thrive.

Recently raised 10 million bucks will be enough for 4 months max. Then it is back to begging bowl. Big plans to initiate and run multiple trials and frankly not enough money to run one trial with a decent sample size.